1-5 of 5
Jose Mariano Hernández
Close
Sort by
Journal Articles

6q Deletion Helps in the Discrimination Between Symptomatic Waldenström's Macroglobulinemia and Asymptomatic Forms of IgM Monoclonal Gammopathies

Ramón García-Sanz, Roberto JP Magalhaes, Enrique M Ocio, MD, PhD, Pilar Giraldo, MD, PhD, Natalia de las Heras, Carmen Aguilera, Jose Mariano Hernández, Alfonso Garcia de Coca, Noemi Puig, Ilda Murillo, MD, Elena Sebastian, MD, Marcos González, Jesus F. San Miguel, MD, PhD, Norma Gutierrez
Journal: Blood
Blood (2012) 120 (21): 4566.
https://doi.org/10.1182/blood.V120.21.4566.4566
Published: 2012
Journal Articles

Smoldering Multiple Myeloma (SMM) At High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) As Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

María-Victoria Mateos, MD, PhD, Lucía López-Corral, Miguel Hernández, Pilar Giraldo, MD, PhD, Javier De La Rubia, Felipe de Arriba, Laura Rosiñol, MD, Juan José Lahuerta, Luis Palomera, Joan Bargay, Albert Oriol, Felipe Prosper, MD, Javier López, Eduardo Olavarría, MD, Maria Luz Martino, MD, Ana-Isabel Teruel, Jose Mariano Hernández, Graça Esteves, Jose Mario JS Mariz, MD, Fernando Leal-da-Costa, MD, Adrian Alegre, MD, Jose-Luis Guzman, Ana López de la Guía, Jose Baquero, Nuria Quintana, Jose Luis García, Jesðs F. San Miguel
Journal: Blood
Blood (2011) 118 (21): 991.
https://doi.org/10.1182/blood.V118.21.991.991
Published: 2011
Journal Articles

Influence of Genetic Polymorphisms in CYP1A2 , CYP2C19, CYP3A4 , GSTP1 , MDR1 and PSMB5 Genes in Toxicity and Response to Induction Therapy in Multiple Myeloma Patients Included in the Trial of the Spanish PETHEMA/GEM 05 for Newly Diagnosed MM Elderly Patients (Age 65 or More)

Cristina Castilla-Llorente, Felipe de Arriba, Virginia Pérez-Andreu, Maria Victoria Mateos, Rocio González-Conejero, José Rivera Pozo, Albert Oriol, Joaquin Martínez-López, Ana Isabel Teruel, Raquel de Paz, José García-Laraña, Enrique Bengoechea, Alejandro Martín, Joaquín Díaz-Mediavilla, Luis Palomera, Yolanda Gonzalez, Jose Mariano Hernández, Anna Sureda, Jose Luis Bello, Joan Bargay, Francisco Javier Peñalver, Maria Luisa Martin Mateos, María Teresa Cibeira, Juan José Lahuerta, Joan Blade, Jesús F. San Miguel
Journal: Blood
Blood (2011) 118 (21): 1412.
https://doi.org/10.1182/blood.V118.21.1412.1412
Published: 2011
Journal Articles

Maintenance Therapy with Bortezomib Plus Thalidomide (VT) or Bortezomib Plus Prednisone (VP) In Elderly Myeloma Patients Included In the GEM2005MAS65 Spanish Randomized Trial

María-Victoria Mateos, MD, PhD, Albert Oriol, Ana-Isabel Teruel, Enrique Bengoechea, Montse Pérez, Javier López, Joaquín Díaz-Mediavilla, Jose Mariano Hernández, Felipe de Arriba, Yolanda Gonzalez, Joan Bladé, MD, Juan José Lahuerta, Jesðs F. San Miguel
Journal: Blood
Blood (2011) 118 (21): 477.
https://doi.org/10.1182/blood.V118.21.477.477
Published: 2011
Journal Articles

Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed Myeloma Patients Treated with A Bortezomib-Based Combination

María-Victoria Mateos, Norma C. Gutierrez, Bruno Paiva, Albert Oriol, Joaquín Martínez-López, Ana Isabel Teruel, Raquel de Paz, Jose Garcia-Laraña, Enrique Bengoechea, Alejandro Martín, Joaquín Díaz-Mediavilla, Luis Palomera, Yolanda Gonzalez, Jose Mariano Hernández, Ana Sureda, Jose Luis Bello, Joan Bargay, Francisco-Javier Penalver, Josep-Maria Ribera, MD, PhD, María-Luisa Martín-Mateos, Ramón García-Sanz, María Teresa Cibeira, MD, PhD, María-Luisa Martín-Ramos, María-Belén Vidriales, María-Angeles Montalbán, Juan-Jose Lahuerta, Joan Blade, Jesús F. San Miguel, Sr, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 309.
https://doi.org/10.1182/blood.V116.21.309.309
Published: 2010